Home > Financial Ratios > TTK HEALTHCARE

TTK HEALTHCARE
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for TTK HEALTHCARE
Please provide your vote to see the results

TTK HEALTHCARE Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 25.42108.7630.47-21.08-35.31

What is the latest Core EBITDA Growth ratio of TTK HEALTHCARE ?

The latest Core EBITDA Growth ratio of TTK HEALTHCARE is 25.42 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar202425.42
Mar2023108.76
Mar202230.47
Mar2021-21.08
Mar2020-35.31

How is Core EBITDA Growth of TTK HEALTHCARE Trending?

Years Core EBITDA Growth % Change
Mar2024 25.42
-76.63
Mar2023 108.76
256.94
Mar2022 30.47
Positive
Mar2021 -21.08
Negative
Mar2020 -35.31 -

Other Financial Ratios of TTK HEALTHCARE


Compare Core EBITDA Growth ratio of peers of TTK HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TTK HEALTHCARE ₹1,855.3 Cr -5.7% -11.4% 0.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,533.0 Cr -3.3% -1.6% 39.9% Stock Analytics
DIVIS LABORATORIES ₹153,076.0 Cr -2.1% -2.8% 48.1% Stock Analytics
CIPLA ₹118,723.0 Cr -1.4% 1.1% 17.1% Stock Analytics
DR REDDYS LABORATORIES ₹112,998.0 Cr 0.3% 9.4% 19.1% Stock Analytics
ZYDUS LIFESCIENCES ₹101,031.0 Cr 4.4% 1.8% 42% Stock Analytics


TTK HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TTK HEALTHCARE

-5.7%

-11.4%

0.8%

SENSEX

-2.3%

-5.1%

7.4%


You may also like the below Video Courses